Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wedbush Upgrades Apellis Pharmaceuticals to Outperform

Wedbush analyst Laura Chico upgrades Apellis Pharmaceuticals (NASDAQ:APLS) from Neutral to Outperform.
byBenzinga Newsdesk
August 19, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Wedbush analyst Laura Chico upgrades Apellis Pharmaceuticals (NASDAQ:APLS) from Neutral to Outperform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0